Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104)Chao Zhang, Wen‐Zhao Zhong|Cell Reports Medicine|2024Cited by 31
Exploring the mechanism of metabolic cell death-related genes AKR1C2 and MAP1LC3A as biomarkers in Parkinson’s diseaseJia Fu, Lifen Yao, Xue Zhao et al.|Scientific Reports|2025Cited by 1